Group of people inside green heart outline.

Clinical Trial Protocols

Recruiting Clinical TrialsProtocolSVH Patient Enrolled
S2212 – Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III StudyProtocolY
NRG-GI008 – Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)ProtocolY
A022104 – Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation (JANUS)ProtocolY
CCTG MA.39 – Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)Protocol
A082002 – Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 NegativeProtocol
A011801 – T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialProtocolY
EA2183 – Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyProtocol
EA5182 – Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerProtocolY
EA3161 – Testing Immunotherapy Versus Observation in Patients With HPV Throat CancerProtocolY
Closed to Enrollment Clinical TrialsProtocolSVH Patient Enrolled
A021703 – Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer (SOLARIS)ProtocolY
ARCADIA – AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke ProtocolY
EA1181 – CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyProtocolY
Zymeworks Expanded Access – An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract CancerProtocolY
A021806 – Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerProtocolY
NRG-GI005 – Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After SurgeryProtocolY